期刊文献+

食管切除术在Barrett食管治疗中的应用进展

Esophagectomy for the Treatment of Barrett’s Esophagus
原文传递
导出
摘要 Barrett食管(Barrett’s esophagus,BE)是发生食管腺癌的重要危险因素。高度不典型增生(high-gradedysplasia,HGD)到腺癌的治疗方法不尽相同,内镜下治疗和抗反流手术存在较高复发率,食管切除术在HGD到腺癌治疗中能够完整切除病变,治疗效果值得肯定,但也要根据不同分期选择不同的手术方式和淋巴结的清扫范围,预后方面淋巴结转移是一个主要的因素。 Barrett's esophagus is considered an important risk factor for the pathogenesis of esophageal adenocarci- noma. Treatment strategies for diseases from high-grade dysplasia (HGD)to adenocarcinoma are different. The recurrence rates of endoscopic treatment and anti-reflux surgery are comparatively higher. Abnormal lesions of the esophagus can be completely resected by esophagectomy for the treatment of HGD to adenocarcinoma, and treatment outcomes are confirmed. But appropriate surgical strategies and lymph node dissection scopes should be chosen according to different cancer staging. Lymph node metastasis is a major factor in determining prognosis.
出处 《中国胸心血管外科临床杂志》 CAS 2013年第2期214-217,共4页 Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
关键词 BARRETT食管 高度不典型增生 食管腺癌 食管切除术 淋巴结清扫 Barrett's esophagus High-grade dysplasia Esophageal adenocarcinoma Esophagectomy Lymph node dissection
  • 相关文献

参考文献40

  • 1Wang KK. Samp liner RE. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol, 2008, [03 (3) : 788-797.
  • 2Fernando HC, Murthy SC, Hofstetter W, et al. The Society of Thoracic Surgeons practice guideline series: guidelines for the management of barrett's esophagus with high-grade dysplasia. Ann Thorac Surg, 2009, 87 (6) : 1993-2002.
  • 3Rastogi A, Puli S, E1-Serag HB, et al. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc, 2008, 67 (3) : 394-398.
  • 4Corley DA, Levin TR, Habel LA. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology,2002, 122(3): 633-640.
  • 5Van S J, van Lanschot JJ, ten Kate FJ, et al. Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junc- tion: implications for therapeutic decision-making. Cancer, 2000, 88 ( 11 ) : 2429-2437.
  • 6Abraham SC, Krasinskas AM, Correa AM, et al. Duplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma. Am J Surg Pathol, 2007, 31 ( 11 ) : 1719-1725.
  • 7Nijhawan PK, Wang KK. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus. Gastrointest Endosc, 2000, 52 (3): 328-332.
  • 8Shaheen NJ, Inadomi JM, Overholt BF, et al. What is the best man- agement strategy for high grade dysplasia in Barrett's oesophagus ? A cost effectiveness analysis. Gut, 2004, 53 ( 12 ) : 1736-1744.
  • 9Wani S, Pull SR, Shaheen N J, et al. Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta- analysis and systematic review. Am J Gastroenterol, 2009, 104 (2) : 502-513.
  • 10Hagen JA, Demeester SR, Peters JH, et al. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagecto- roles. Ann Surg, 2001,234(4): 520-530.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部